2025 Speakers

 

13-16 October 2025
RAI Congress Centre, Amsterdam

 

 

Jeffrey Almond, Former VP Discovery R&D, Sanofi & Visiting Professor, University of Oxford - Oxford Vaccine Group

Jeffrey Almond | Former VP Discovery R&D, Sanofi & Visiting Professor | University of Oxford - Oxford Vaccine Group » speaking at Vaccine Congress Europe

Maria Alriksson, CEO, Abera Bioscience AB

Maria Alriksson | CEO | Abera Bioscience AB » speaking at Vaccine Congress Europe

Aleksandar Antanasijevic, Tenure Track Assistant Professor, Global Health Institute, École Polytechnique Fédérale de Lausanne (EPFL)

Jane Marie Barratt, Global Advisor and Former Secretary General, International Federation on Ageing

Daniel Becker, Head of Business Development INACTIVATE, KyooBe Tech GmbH

Daniel Becker | Head of Business Development INACTIVATE | KyooBe Tech GmbH » speaking at Vaccine Congress Europe

Ana Bernado-Cancedo, Senior Associate, NATO Innovation Fund

Ana Bernado-Cancedo | Senior Associate | NATO Innovation Fund » speaking at Vaccine Congress Europe

Maria Elena Bottazzi, Co-Director of Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine

Ed Buurman, Director Alliances, CARB-X

Marco Cavaleri, Head of Public Health Threats, EUROPEAN MEDICINES AGENCY

Nicolas Collin, Co-Founder and Chief Executive Officer, Vaccine Formulation Institute CH Ltd

Nicolas Collin | Co-Founder and Chief Executive Officer | Vaccine Formulation Institute CH Ltd » speaking at Vaccine Congress Europe

Tim Cooke, CEO, Omniose

Benjamin Damien, CEO, Sagitta Biotech

Benjamin Damien | CEO | Sagitta Biotech » speaking at Vaccine Congress Europe

Kyle Doolan, Director of Research, Integral Molecular

Carel Du Marchie Sarvaas, Executive Director, HealthforAnimals

Jay Evans, Chief Scientific and Strategy Officer, Inimmune

Jay Evans | Chief Scientific and Strategy Officer | Inimmune » speaking at Vaccine Congress Europe

David Farcas, Director, Chile, Yelcho

David Farcas | Director, Chile | Yelcho » speaking at Vaccine Congress Europe

Thom Frielink, Associate, Curie Capital BV

Thom Frielink | Associate | Curie Capital BV » speaking at Vaccine Congress Europe

Christina Go, Application Scientist, Integral Molecular

Bassam Hallis, Deputy Director, Vaccine Development & Evaluation Centre, UK Health Security Agency

Jonathan Hare, Translational Scientist, The Francis Crick Institute

Jonathan Hare | Translational Scientist | The Francis Crick Institute » speaking at Vaccine Congress Europe

Mark Howarth, Sheild Chair of Pharmacology, University Of Cambridge

Lennard Lee, Associate Professor, University of Oxford

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital

Stephen Lockhart, Director, Senior Consultant, HURST GRANGE ASSOCIATES

Mats Lundgren, CSO, Abera Bioscience AB

Gerben Marsman, Head of Alliance Management, Vaccine Formulation Institute

Michael Miller, Consultant - Author, HealthPolCom

Kayvon Modjarrad, Executive Director, Viral Vaccines, Pfizer

Kayvon Modjarrad | Executive Director, Viral Vaccines | Pfizer » speaking at Vaccine Congress Europe

Elise Pepermans, Chief Executive Officer, ImmuneSpec BV

Wolfgang Philipp, Principal Adviser, Chief Science Officer, European Commission Health Emergency Preparedness & Response (HERA)

Wolfgang Philipp | Principal Adviser, Chief Science Officer | European Commission Health Emergency Preparedness & Response (HERA) » speaking at Vaccine Congress Europe

Giovanna Riggall, Head of Heath Supply Chain, Unimed

Giovanna Riggall | Head of Heath Supply Chain | Unimed » speaking at Vaccine Congress Europe

Meta Roestenberg, Clinical Head, Controlled Human Infection Center, Leiden University Medical Center (Netherlands)

Simona Rondini, Head Bacterial Projects and Senior Project Leader, GSK Vaccines

Simona Rondini | Head Bacterial Projects and Senior Project Leader | GSK Vaccines » speaking at Vaccine Congress Europe

Jerald Sadoff, Chief Medical Officer, Centivax

Jeremy Salt, Chief Executive Officer, The Vaccine Group

Jeremy Salt | Chief Executive Officer | The Vaccine Group » speaking at Vaccine Congress Europe

Tyler Sandberg, Product Manager, ELISpot & FluoroSpot, MABTECH

Maite Segurola, Head Life Sciences Portfolio, Cocoon Bioscience

Maite Segurola | Head Life Sciences Portfolio | Cocoon Bioscience » speaking at Vaccine Congress Europe

Miriam Taegtmeyer, Professor of Global Health, London School of Hygiene and Tropical Medicine

Miriam Taegtmeyer | Professor of Global Health | London School of Hygiene and Tropical Medicine » speaking at Vaccine Congress Europe

Robbert Van der Most, CEO, Vaxxcellence

Robbert Van der Most | CEO | Vaxxcellence » speaking at Vaccine Congress Europe

Bruno Vandelanotte, Sales Manager EMEA, Roncadelle-Operations

Bruno Vandelanotte | Sales Manager EMEA | Roncadelle-Operations » speaking at Vaccine Congress Europe

Vanessa Vankerckhoven, CEO, IDEVAX

Vanessa Vankerckhoven | CEO | IDEVAX » speaking at Vaccine Congress Europe

Roland Ventura, VFI Senior Advisor for Strategy, Vaccine Formulation Institute

Roland Ventura | VFI Senior Advisor for Strategy | Vaccine Formulation Institute » speaking at Vaccine Congress Europe

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK


Anna Hindley-Skelt
Anna.Hindley-Skelt@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.